Celldex Therapeutics, Inc.
CLDX
Revenue
2.50M
▲2.34M▲1501.28%
3 Months ChangeAssets
845.59M
▼-23.26M▼-2.68%
3 Months ChangeLiabilities
31.93M
▲1.69M▲5.60%
3 Months ChangeFree Cash Flow
-40.98M
▼-11.83M▼-40.57%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0001410578-24-001219
2024-08-08
Form 8-K
ID: 0001171843-24-004603
2024-06-14
Form 8-K
ID: 0001104659-24-071512
2024-05-06
Form 10-Q
ID: 0001410578-24-000593
2024-05-06
Form 8-K
ID: 0001171843-24-002570
2024-03-01
Form 8-K
ID: 0001104659-24-029969
2024-02-26
Form 8-K
ID: 0001171843-24-000966
2023-11-08
Form 8-K
ID: 0001104659-23-115796
2023-11-06
Form 8-K
ID: 0001104659-23-114520
2023-11-02
Form 10-Q
ID: 0001410578-23-002169